Oseltamivir reduces flu complications: study
The drug was also shown to shorten the duration of flu symptoms by about a day compared to placebo in adults with laboratory-confirmed influenza.
According to the researchers, the analysis confirmed that treatment with oseltamivir (Tamiflu, Roche) is associated with a significantly increased risk of nausea compared with placebo. They said that whether the magnitude of the drug’s benefits outweighs the harms of nausea and vomiting needs “careful consideration”.
The drug has been stockpiled and widely used by governments around the